Treatment Options for Recurrent Genital Herpes
For recurrent genital herpes, the recommended treatments are valacyclovir 500 mg twice daily or 1000 mg once daily for 5 days, acyclovir 800 mg three times daily for 2 days, or famciclovir 1000 mg twice daily for 1 day for episodic treatment, with valacyclovir 1000 mg daily or acyclovir 400 mg twice daily for suppressive therapy in patients with frequent recurrences. 1
Oral Antiviral Medications
Episodic Treatment Options
Episodic treatment should be initiated at the first sign of prodrome or lesions:
Valacyclovir:
Acyclovir:
Famciclovir:
Suppressive Treatment Options
For patients with ≥6 recurrences per year, suppressive therapy is recommended:
Valacyclovir:
Acyclovir:
Topical Treatment Options
- Acyclovir cream 5%:
Symptomatic Relief Measures
Topical options:
Systemic options:
Special Considerations
Renal Impairment
Dose adjustments are necessary for patients with reduced renal function:
Valacyclovir:
- CrCl ≥50 mL/min: No adjustment needed
- CrCl 30-49 mL/min: No adjustment needed
- CrCl 10-29 mL/min: 500 mg every 24 hours
- CrCl <10 mL/min: 500 mg every 24 hours 1
Acyclovir (for recurrent genital herpes):
- CrCl ≥50 mL/min: 500 mg every 12 hours
- CrCl 30-49 mL/min: No reduction
- CrCl 10-29 mL/min: 500 mg every 24 hours
- CrCl <10 mL/min: 500 mg every 24 hours 1
HIV-Infected Patients
Higher doses may be necessary:
- Acyclovir 400 mg orally 3-5 times daily 1
- For suppressive therapy in HIV patients: Acyclovir 500 mg every 12 hours (with normal renal function) 1
Patient Education and Counseling
- Instruct patients to:
- Apply medication at the first sign of prodrome 1
- Wash hands before and after application 1
- Complete the full course of treatment even if symptoms improve 1
- Abstain from sexual activity during outbreaks or prodromal symptoms 1
- Use condoms consistently to reduce transmission risk 1
- Be aware of asymptomatic viral shedding and transmission risk 1
Common Pitfalls and Caveats
- Delayed treatment initiation: Treatment is most effective when started within the first 24 hours of symptoms
- Inadequate dosing: Ensure proper dosing based on frequency of recurrences and renal function
- Poor adherence: Once-daily valacyclovir may improve compliance compared to multiple daily doses 4, 6
- Failure to adjust for renal impairment: Dose adjustments are essential to prevent toxicity in patients with reduced renal function 1, 3
- Discontinuation of suppressive therapy: Recurrences typically return to pre-treatment frequency after stopping suppressive therapy 5, 7